Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can extra salt stop seniors from falling? new trial investigates

NCT ID NCT06188663

Symptom relief Sponsor: University of Galway Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether taking extra salt (5 grams per day in capsules) can improve symptoms and quality of life in older adults (65+) who experience dizziness and falls due to orthostatic hypotension. The trial involves 42 participants and lasts 12 months, focusing on whether such a study is feasible and whether salt helps reduce symptoms and blood pressure drops upon standing. It also checks for potential heart risks from increased salt intake.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
salt (sodium chloride) capsules
What this could lead to
If it works, this could point toward a simple, low-cost dietary supplement to ease dizziness and reduce fall risk in older adults with orthostatic hypotension.
What could go wrong
This is a small, early-phase feasibility trial with only 42 participants, so results may not be conclusive. High salt intake might also raise cardiovascular risks, which the study will monitor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

42 people

The number who actually took part.

Started

Jul 2024

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults ≥ 65 years of age * Documented history of orthostatic hypotension, defined by decrease in systolic blood pressure (SBP) of ≥20 mmHg or a decrease in diastolic blood pressure (DBP) of ≥10 mmHg within three minutes of standing when compared with blood pressure from the supine position, or at head-up tilt testing. * A documented history of symptoms consistent with orthostatic hypotension including one of the following: light-headedness, dizziness, feeling faint, feeling like they may black out * Baseline salt intake expected to be in the moderate range (5-10g/day) based on screening questions * Willingness to supplement sodium intake * Ability to provide written informed consent Exclusion Criteria: * Severe supine hypertension (Systolic blood pressure≥180mmHg or diastolic blood pressure \>110mmHg) measured as average of three office readings * A diagnosis of Heart Failure (New York Heart Association (NYHA) Class III or IV symptoms or known left ventricular ejection fraction 30%, if more than one echo eligibility is defined by most recent echo) * CKD (eGFR \<30ml/min/1.73m2) based on eGFR measured within the last 6 months * Participants taking loop diuretics * Serum sodium \<125mmol at last measurement * Acute intercurrent illness * Prescribed high-salt diet (for clinical indication other than for OH) or low-salt diet for evidence based clinical indication * Participant unlikely to comply with study procedures or follow-up visits due to severe comorbid illness or other factor (e.g. inability to travel for follow-up visits) in opinion of research team * Inability to provide informed consent in the opinion of the investigator (for example due to severe cognitive impairment)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Orthostatic hypotension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hypotension, Orthostatic orthostatic hypotension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Orthostatic hypotension

Contacts and locations

Locations

  • Clinical Research Facility Galway/Galway University Hospital

    Galway, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.